PRQR   $0.9499  -2.66% Market Closed

ProQR Therapeutics NV
Total Cash 96.15M
totalCashPerShare 1.177
EBITDA -27.33M
Total Debt 19.19M
quickRatio 2.701
currentRatio 2.73
Total Revenue 15.78M
debtToEquity 58.41
Revenue/Share 0.194
ROA -0.1328
ROE -0.5039
grossProfits
freeCashflow 2.43M
operatingCashflow -34.22M
earningsGrowth
revenueGrowth 4.198
grossMargins 1.0
ebitdaMargins -1.7322301
operatingMargins -0.55719
profitMargins -1.3656399
enterpriseValue 74.15M
forwardPE -3.7
floatShares 57.82M
sharesOutstanding 81.68M
sharesShort 165.86K
sharesShortPriorMonth 162.52K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.18%
heldPercentInstitutions 0.38%
Short Ratio help_outline 1.14%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.402
Price To Book help_outline 4.60
earningsQuarterlyGrowth
netIncomeToCommon -21.54M
trailingEps -0.30%
forwardEps -0.50%
enterpriseToEbitda -2.71
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.12 3Q 2024
institutionsCount 57
lastUpdated Sept. 16, 2024, 12:42 p.m.